Background Antiphospholipid syndrome (APS) is characterized by the presence circulating
antiphospholipid (aPL) antibodies in patients with thrombosis or pregnancy morbidity …

Objectives Anti-β2 glycoprotein I domain I (anti-domain I) and anti-phosphatidylserine/
prothrombin (aPS/PT) antibodies are present in patients with antiphospholipid syndrome …

Background Antiphospholipid syndrome (APS) is an autoimmune condition that is
diagnosed by the presence of at least one of the clinical manifestations (thrombosis and/or …

The diagnosis of antiphospholipid syndrome (APS) relies on the detection of
antiphospholipid antibodies (aPL). Currently, lupus anticoagulant (LA), anticardiolipin (aCL) …

Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by clinical
symptoms of vascular thrombosis and/or pregnancy morbidity in the presence of …

The updated international consensus criteria for definite antiphospholipid syndrome (APS)
are useful for scientific clinical studies. However, there remains a need for diagnostic criteria …

The international classification criteria for definite antiphospholipid syndrome (APS) include
three laboratory measurements: lupus anticoagulant (LA), IgG and IgM isotypes of anti …

Diagnosis of antiphospholipid syndrome (APS) requires the presence of a clinical criterion
(thrombosis and/or pregnancy morbidity), combined with persistently circulating …

Current classification criteria for definite antiphospholipid syndrome (APS) mandate the use
of one or more of three positive 'standardized'laboratory assays to detect antiphospholipid …

Background The anti-phospholipid syndrome (APS) is characterized by thrombosis and/or
pregnancy morbidity with persistent presence of anti-phospholipid antibodies (aPL) …